Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Shares Outstanding (Diluted Average) (2021 - 2025)

iBio (IBIO) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $99.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1016.36% to $99.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $99.1 million, a 1016.36% increase, with the full-year FY2025 number at $10.5 million, up 174.05% from a year prior.
  • Shares Outstanding (Diluted Average) was $99.1 million for Q4 2025 at iBio, up from $53.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $188.5 million in Q1 2021 to a low of $466000.0 in Q4 2022.
  • A 5-year average of $22.0 million and a median of $8.7 million in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): crashed 95.37% in 2022, then soared 1016.36% in 2025.
  • iBio's Shares Outstanding (Diluted Average) stood at $8.7 million in 2021, then crashed by 94.65% to $466000.0 in 2022, then soared by 227.25% to $1.5 million in 2023, then skyrocketed by 482.3% to $8.9 million in 2024, then skyrocketed by 1016.36% to $99.1 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Shares Outstanding (Diluted Average) are $99.1 million (Q4 2025), $53.0 million (Q3 2025), and $10.5 million (Q2 2025).